SiNtx Technologies Inc (SINT)

[SmokerX]

"CTL Medical Corporation has entered into a definitive agreement with Amedica Corporation (NASDAQ: AMDA) to purchase its commercial spine business, which includes its complete portfolio of spine-related patents and 510ks, as well as any technological advancements directly related to the spine that result from it."

Looks pretty official that CTL is gaining the IP R&D with Amedica tweeting to confirm this is true. Not sure how you can translate this into something good for Shareholders with the price tag of $10 million for US spine and all Silicon nitride spine IP R&D and any R&D that occurs into the future involving spine and any inventory they have laying around. I take back what I said before. Amedica should not tweet.